INVENTIVA PHARMA
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology. They have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
INVENTIVA PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Medical Medical Device
Founded:
2011-01-01
Address:
Daix, Bourgogne, France
Country:
France
Website Url:
http://www.inventivapharma.com
Total Employee:
101+
Status:
Active
Contact:
+33 (0)3 80 44 75 00
Email Addresses:
[email protected]
Total Funding:
139.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
AbbVie
AbbVie investment in Grant - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Official Site Inspections
http://www.inventivapharma.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.22 K
- Host name: vs16.mygoldennetwork.cognix-systems.net
- IP address: 146.59.140.137
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
More informations about "Inventiva Pharma"
About Inventiva - Inventiva Pharma
Cookie Duration Description; ak_bmsc: 2 hours: This cookie is used by Akamai to optimize site security by distinguishing between humans and bots: cookielawinfo-checkbox-advertisementSee details»
Leadership - Inventiva Pharma
Jean Volatier. Chief Financial Officer. Jean has served as our Chief Financial Officer since August 2012. Previously, Mr. Volatier was a senior consultant for I Care Environnement, a consulting …See details»
Inventiva Pharma - Crunchbase Company Profile
Contact Email [email protected] Phone Number +33 (0)3 80 44 75 00 Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with …See details»
Inventiva Company Profile | Management and Employees List
Www.inventivapharma.com Inventiva Profile and History Founded in 2012 and headquartered in France, Inventiva is a clinical-stage biopharmaceutical company focused on the development …See details»
Inventiva Pharma - Org Chart, Teams, Culture & Jobs | The Org
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the …See details»
Inventiva Pharma - LinkedIn
Inventiva Pharma | 5,976 followers on LinkedIn. A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. | Inventiva is a clinical-stage ...See details»
Inventiva Pharma - PitchBook
Inventiva Pharma General Information Description. Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation.See details»
Inventiva S.A. (EPA: IVA) Company Profile & Overview - Stock …
Nov 22, 2024 Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis …See details»
Inventiva Pharma - LinkedIn
Inventiva Pharma | 4,929 followers on LinkedIn. A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. | Inventiva is a clinical-stage …See details»
Inventiva - Overview, News & Similar companies | ZoomInfo.com
Inventiva contact info: Phone number: +33 380447500 Website: www.inventivapharma.com What does Inventiva do? Founded in 2012 and headquartered in France, Inventiva is a clinical-stage …See details»
Inventiva Company Profile - Craft
Oct 29, 2024 Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases. It focuses on diseases with a high unmet medical …See details»
Inventiva announces the schedule of publication and ... - BioSpace
Mar 23, 2023 [email protected] +1 240 620 9175: Brunswick Group Tristan Roquet Montegon / Aude Lepreux Matthieu Benoist Media relations [email protected] …See details»
Inventiva and Sino Biopharm announce licensing and
Sep 21, 2022 Inventiva Pascaline Clerc, VP of Global External Affairs [email protected] +1 240 620 9175 Brunswick Group Laurence Frost /Tristan …See details»
Inventiva's IVA337 Given Generic Name “Lanifibranor” by the …
Daix (France), September 18, 2017 at 05:45pm CEST – Inventiva, a biopharmaceutical company developing innovative breakthrough therapies, particularly for the treatment of fibrotic …See details»
Investors - Inventiva Pharma
Feb 13, 2019 Email: [email protected] Tel: +33 (0)3 80 44 75 00. Patti Bank Managing Director ICR Westwicke [email protected] D 415-513-1284 San …See details»
Inventiva S.A. (IVA) Stock Price, Quote & News - Stock Analysis
Nov 21, 2024 Website https://www.inventivapharma.com. Full Company Profile. Financial Performance. In 2023, Inventiva's revenue was 23.16 million, an increase of 23.12% …See details»
Inventiva announces the initiation of its pivotal Phase III
Sep 8, 2021 Inventiva Pascaline Clerc VP of Global External Affairs [email protected] +1 240 620 9175 : Brunswick Group Yannick Tetzlaff / Tristan …See details»
Press Releases - Inventiva Pharma
Inventiva’s IVA337 Given Generic Name “Lanifibranor” by the World Health Organization (WHO) ... [email protected] +1 202 499 8937. Brunswick Tristan Roquet …See details»
News & Events - Inventiva Pharma
[email protected] +1 240 620 9175. Brunswick Laurence Frost / Tristan Roquet Montegon / Aude Lepreux Media relations [email protected] +33 1 53 …See details»